Catalyst Wire Dossier Catalyst Wire Dossier

Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation

albuterol · Aurobindo Pharma Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation, covering 2022-05-20 to 2022-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation [Phase 3]

See pricing